COVID-19 neutralising antibody test, AbC-19, available to CLIA testing labs in the USA following the completion of FDA Section IV.D by Abingdon Health
A statement from Abingdon Health in response to media speculation around the AbC-19 assay.
Learn how the flexibility of rapid tests help with proving vaccine efficacy when needing to test the widest cohort.
UK Government enters into a contract for supply of COVID-19 rapid antibody tests and places its first order for one million COVID-19 AbC-19 tests.
The independent report compares the Roche and Abbott immunoassays to detect SARS-CoV2 antibodies, alongside the EuroImmun IgG SARS-CoV-2 ELISA.
Abingdon Health, the lead in the UK-Rapid Test Consortium (UK-RTC), achieves CE marking for AbC-19 Rapid Test.
Abingdon Health is delighted to announce the UK-RTC has reached design freeze for the AbC-19TM lateral flow test for IgG antibodies to the...
The UK-RTC has made significant progress in developing a COVID-19 lateral flow antibody test that can be used by people in their homes,...